Huntsville, ALNCT06218199Now EnrollingIRB Ready

Heart Failure, Congestive Clinical Trial in Huntsville, AL

Access cutting-edge heart failure, congestive treatment through this clinical trial at a research site in Huntsville. Study-provided care at no cost to qualified participants.

Sponsored by Heart Center Research, LLC

Quick Self-Assessment

See if you qualify for this Huntsville location

Preparing your pre-screening questions…

Expert Care in Huntsville

Access heart failure, congestive specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related heart failure, congestive treatment provided free

Apply for This Huntsville Location

Check if you qualify for this heart failure, congestive clinical trial in Huntsville, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Huntsville

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Huntsville site if eligible
  4. 4Begin participation

About This Heart Failure, Congestive Study in Huntsville

The DART-HA study is a single-center, open label, trial intended to evaluate the clinical efficacy of standard treatment options for congestive heart failure (observation, diuretic or afterload reduction therapy) in patients without new symptoms who have developed abnormalities of the HeartLogic heart failure diagnostic feature.

Sponsor: Heart Center Research, LLC

Who Can Participate

Inclusion Criteria

Boston Scientific device with HeartLogic enabled
Lack of standard contraindications to Sacubitril/valsartan:
history of ACE-inhibitor induced angioedema and in those with angiotensin II receptor blocker (ARB) therapy induced angioedema.
hypotension, hypovolemia
renal artery stenosis, renal failure
hyperkalemia
hepatic disease Child-Pugh class C
Pregnancy/Breast-feeding
Lack of standard contraindications to diuretic therapy
Systolic Blood Pressure \> 105

Exclusion Criteria

Glomerular filtration rate \<25 mL/min who are non-responsive to diuretic therapy or are on chronic renal dialysis
ongoing symptoms of heart failure decompensation (increased dyspnea and/or fatigue, for purposes of this study increased weight is not considered, see question 2 KCCQ).
recent significant change in arrhythmia burden (within the past 2 weeks)
in cardiac resynchronization therapy (CRT) patients, recent change (60 days) in effective delivery of CRT (eg. decreased biventricular paving %)
the subject is unable to sign or refuses to sign the patient informed consent
Symptomatic heart failure at rest or New York Heart Association Class IV at the time of enrollment
the subject is implanted with unipolar right atrial or right ventricular leads
subject has received or is scheduled to receive a heart transplant or ventricular assist device within the next 6 months
subject is pregnant or planning to become pregnant during the study
regularly scheduled IV heart failure therapy (e.g. inotropes or diuretics)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Huntsville?

Yes, this clinical trial (NCT06218199) has an active research site in Huntsville, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Heart Failure, Congestive Treatment Options in Huntsville, AL

If you're searching for heart failure, congestive treatment options in Huntsville, AL, this clinical trial (NCT06218199) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Huntsville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure, congestive specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all heart failure, congestive clinical trials near you to find additional studies recruiting in your area.

More Heart Failure Trials in Huntsville, AL

See all heart failure clinical trials recruiting in Huntsville — not just this study.

Browse Heart Failure Trials in Huntsville →

Browse More Trials by Condition

Heart Failure TrialsFanconi Anemia TrialsAll Conditions →

Ready to Join in Huntsville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Huntsville, AL